Previous Close | 1,226.25 |
Open | 1,249.00 |
Bid | 1,220.80 x 0 |
Ask | 1,220.90 x 0 |
Day's Range | 1,213.10 - 1,249.00 |
52 Week Range | 662.35 - 1,264.50 |
Volume | |
Avg. Volume | 23,129 |
Market Cap | 344.594B |
Beta (5Y Monthly) | 0.83 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -67.32 |
Earnings Date | Aug 07, 2024 - Aug 21, 2024 |
Forward Dividend & Yield | 2.50 (0.20%) |
Ex-Dividend Date | Sept 18, 2023 |
1y Target Est | 601.93 |
Shares of Mumbai-based Glenmark Pharmaceuticals fell 4.5% to Rs 790.25 on the National Stock Exchange (NSE) in early trade on Friday, following the company's announcement of a significant divestment in its subsidiary, Glenmark Life Sciences. The decline came after the stock reached a 52-week high of Rs 880 on Thursday.